outstanding JJ Oas IN Oof IN OSept. NNP B30 CD I. . OIn IN Onational JJ Bover-the-counter JJ Itrading NN Iyesterday NN B, , OUS PRP BFacilities NNPS Iclosed VBD Oat IN O$ $ B3.625 CD I, , Ounchanged JJ O. . OThree CD Bleading VBG Idrug NN Icompanies NNS Ireported VBD Orobust JJ Bthird-quarter JJ Iearnings NNS I, , Obolstered VBN Oby IN Ostrong JJ Bsales NNS Iof IN Onewer JJR B, , Ibig-selling JJ Iprescriptions NNS Idrugs NNS Ithat WDT Bprovide VBP Ohefty JJ Bprofit NN Imargins NNS I. . OMerck NNP B& CC ICo. NNP Ireported VBD Oa DT B25 CD I% NN Iincrease NN Iin IN Oearnings NNS B; : OWarner-Lambert NNP BCo. NNP I's POS Bprofit NN Irose VBD O22 CD B% NN Iand CC OEli NNP BLilly NNP I& CC ICo. NNP I's POS Bnet JJ Iincome NN Irose VBD O24 CD B% NN I. . OThe DT Bresults NNS Iwere VBD Oin IN Oline NN Bwith IN Oanalysts NNS B' POS Bexpectations NNS I. . OMerck NNP B& CC ICo NNP I. . IMerck NNP B, , ORahway NNP B, , ON.J. NNP B, , Ocontinued VBD Oto TO Olead VB Othe DT Bindustry NN Iwith IN Oa DT Bstrong JJ Isales NNS Iperformance NN Iin IN Othe DT Bhuman NN Iand CC Ianimal NN Ihealth-products NNS Isegment VBP I. . OA DT Bstronger JJR IU.S. NNP Idollar NN Ireduced VBD Othird-quarter JJ Band CC Ifirst-nine-month JJ Isales NNS Igrowth NN I2 CD B% NN Iand CC I3 CD I% NN I, , Orespectively RB O. . OInternational JJ Bsales NNS Iaccounted VBD Ofor IN O47 CD B% NN Iof IN Ototal JJ Bcompany NN Isales NNS Ifor IN Othe DT Bnine CD Imonths NNS I, , Ocompared VBN Owith IN O50 CD B% NN Ia DT Byear NN Iearlier RBR O. . OSales NNS Bfor IN Othe DT Bquarter NN Irose VBD Oto TO O$ $ B1.63 CD Ibillion CD Ifrom IN O$ $ B1.47 CD Ibillion CD I. . OMevacor NNP B, , OMerck NNP B's POS Bnew JJ Icholesterol-lowering JJ Idrug NN I, , Ohad VBD Ohigher JJR Bvsales NNS Ithan IN Oany DT Bother JJ Iprescription NN Imedicine NN Ihas VBZ Oever RB Oachieved VBN Oin IN Othe DT BU.S. NNP Iin IN Othe DT Byear NN Ifollowing VBG Ointroduction NN B, , Othe DT Bcompany NN Isaid VBD O. . OThe DT Bdrug NN Iwas VBD Ointroduced VBN Oin IN OWest NNP BGermany NNP Ithis DT Byear NN I. . OIntense JJ Bcompetition NN I, , Ohowever RB O, , Oled VBN Oto TO Ounit NN Bsales NNS Ideclines NNS Ifor IN Oa DT Bgroup NN Iof IN OMerck NNP B's POS Bestablished VBN Ihuman NN Iand CC Ianimal-health NN Iproducts NNS I, , Oincluding VBG OAldomet NNP Band CC IIndocin NNP I. . OIn IN ONew NNP BYork NNP IStock NNP IExchange NNP Icomposite JJ Itrading NN Iyesterday NN B, , OMerck NNP Bshares NNS Iclosed VBD Oat IN O$ $ B75.25 CD I, , Oup IN O50 CD Bcents NNS I. . OWarner-Lambert NNP BCo NNP I. . IWarner-Lambert NNP B, , OMorris NNP BPlains NNP I, , ON.J. NNP B, , Oreported VBD Osales NNS Bthat WDT Bwere VBD Oa DT Brecord NN Ifor IN Oany DT Bquarter NN Iand CC Othe DT Beighth JJ Iquarter NN Iin IN Oa DT Brow NN Iof IN O20 CD B% NN Ior CC Imore RBR Iper-share JJ Iearnings NNS Igrowth NN I. . OSpurred VBN Oby IN Ogrowth NN Bin IN Oworld-wide JJ Bsales NNS Iof IN Othe DT Bcompany NN I's POS Bprescription NN Idrugs NNS I, , OWarner-Lambert NNP Bsaid VBD O1989 CD Bwill MD Obe VB Othe DT Bbest JJS Iyear NN Iin IN Oits PRP$ Bhistory NN I, , Owith IN Oper-share JJ Bearnings NNS Iexpected VBN Oto TO Oincrease VB Omore JJR Bthan IN I20 CD I% NN Ito TO Oabout RB B$ $ I6.10 CD I. . OSales NNS Bfor IN Othe DT Bquarter NN Irose VBD Oto TO O$ $ B1.11 CD Ibillion CD Ifrom IN O$ $ B1.03 CD Ibillion CD I. . OPrescription-drug NN Bworld-wide JJ Isales NNS Irose VBD O9 CD B% NN Iin IN Othe DT Bquarter NN Ito TO O$ $ B340 CD Imillion CD I; : OU.S. NNP Bsales NNS Irose VBD O15 CD B% NN I. . OThe DT Bsegment NN I's POS Bgrowth NN Iwas VBD Oled VBN Oby IN Osales NNS Bof IN Othe DT Bcardiovascular JJ Idrugs NNS ILopid NNP B, , Oa DT Blipid NN Iregulator NN I, , Oand CC ODilzem NNP B, , Oa DT Bcalcium NN Ichannel NN Iblocker NN I. . OWorld-wide JJ Bsales NNS Iof IN OWarner-Lambert NNP B's POS Bnon-prescription JJ Ihealth-care NN Iproducts NNS I, , Osuch JJ Oas IN OHalls NNP Bcough NN Itablets NNS I, , ORolaids NNP Bantacid NN I, , Oand CC OLubriderm NNP Bskin NN Ilotion NN I, , Oincreased VBN O3 CD B% NN Ito TO O$ $ B362 CD Imillion CD Iin IN Othe DT Bthird JJ Iquarter NN I; : OU.S. NNP Bsales NNS Irose VBD O5 NN B% NN I. . OConfectionery JJ Bproducts NNS Isales NNS Ialso RB Ohad VBD Ostrong JJ Bgrowth NN Iin IN Othe DT Bquarter NN I. . OWorld-wide JJ Bsales NNS Iof IN OTrident NNP Bgum NN I, , OCerts NNP Bbreath NN Imints NNS I, , Oand CC OClorets NNP Bgum NN Iand CC Ibreath NN Imints NNS I, , Oincreased VBN O12 CD B% NN Ito TO O$ $ B277 CD Imillion CD I. . OWarner-Lambert NNP Bshares NNS Iclosed VBD Oat IN O$ $ B109.50 CD Ia DT Bshare NN I, , Oup IN O$ $ B1.50 CD I, , Oin IN OBig NNP BBoard NNP Icomposite JJ Itrading NN Iyesterday NN B. . OEli NNP BLilly NNP I& CC ICo NNP I. . ILilly NNP Battributed VBD Orecord NN Bthird-quarter JJ Iand CC Inine-month JJ Iresults NNS Ito TO Oworld-wide JJ Bgains NNS Ifor IN Opharmaceuticals NNS B, , Omedical JJ Binstruments NNS Iand CC Oplant-science NN Bproducts NNS Idespite IN Opoor JJ Bexchange NN Irates NNS Ifor IN Othe DT Bdollar NN Ithat WDT Bslowed VBD Osales NNS Babroad RB O. . OEarnings NNS Bcontinued VBD Oto TO Opace VB Osales NNS Bbecause IN Oof IN Oa DT Blower JJR Itax NN Irate NN I, , Oprofit NN Bfrom IN Othe DT Brenegotiation NN Iof IN Othe DT Bdebt NN Iinstrument NN Ireceived VBD Ofrom IN OFaberge NNP BInc. NNP Iin IN Oconnection NN Bwith IN OLilly NNP B's POS Bsale NN Iof IN OElizabeth NNP BArden NNP IInc. NNP Iin IN O1987 CD B, , Oand CC Onet JJ Bproceeds NNS Ifrom IN Othe DT Bsettlement NN Iof IN Opatent NN Blitigation NN Iat IN OLilly NNP B's POS BHybritech NNP IInc. NNP Iunit NN I. . OThird-quarter JJ Bsales NNS Iof IN Othe DT BIndianapolis NNP I, , IInd. NNP I, , Icompany NN Irose VBD O11 CD B% NN Ito TO O$ $ B1.045 CD Ibillion CD Ifrom IN O$ $ B940.6 CD Imillion CD I. . ONine-month JJ Bsales NNS Igrew VBD O12 CD B% NN Ito TO O$ $ B3.39 CD Ibillion CD Ifrom IN O$ $ B3.03 CD Ibillion CD Ia DT Byear NN Iearlier RBR O. . OSales NNS Bof IN OProzac NNP B, , Oan DT Banti-depressant NN I, , Oled VBN Odrug-sales NNS Bincreases NNS I. . OHigher JJR Bsales NNS Iof IN Opesticides NNS Band CC Oother JJ Bplant-science NN Iproducts NNS Imore JJR Othan IN Ooffset VB Oa DT Bslight JJ Idecline NN Iin IN Othe DT Bsales NNS Iof IN Oanimal-health NN Bproducts NNS Ito TO Ofuel VB Othe DT Bincrease NN Iin IN Oworld-wide JJ Bagricultural JJ Iproduct NN Isales NNS I, , OLilly NNP Bsaid VBD O. . OAdvanced NNP BCardiovascular NNP ISystems NNP IInc. NNP Iand CC OCardiac NNP BPacemakers NNPS IInc. NNP Iunits NNS Iled VBD Ogrowth NN Bin IN Othe DT Bmedical-instrument JJ Isystems NNS Idivision NN I. . OLilly NNP Bshares NNS Iclosed VBD Oyesterday NN Bin IN Ocomposite JJ Btrading NN Ion IN Othe DT BBig NNP IBoard NNP Iat IN O$ $ B62.25 CD I, , Odown RB O12.5 CD Bcents NNS I. . OReuben NNP BMark NNP I, , Ochairman NN Bof IN OColgate-Palmolive NNP BCo. NNP I, , Osaid VBD Ohe PRP Bis VBZ O`` `` Ocomfortable JJ O'' '' Owith IN Oanalysts NNS B' POS Bestimates NNS Ithat IN Othird-quarter JJ Bearnings NNS Irose VBD Oto TO Obetween IN B95 CD Icents NNS Iand CC I$ $ I1.05 CD Ia DT Bshare NN I. . OThat DT Bcompares VBZ Owith IN Oper-share JJ Bearnings NNS Ifrom IN Ocontinuing VBG Boperations NNS Iof IN O69 CD Bcents NNS Ithe DT Byear NN Iearlier RBR O; : Oincluding VBG Odiscontinued VBN Boperations NNS I, , Oper-share NN Bwas VBD O88 CD Bcents NNS Ia DT Byear NN Iago RB O. . OThe DT Bper-share JJ Iestimates NNS Imean VBP Othe DT Bconsumer-products NNS Icompany NN I's POS Bnet JJ Iincome NN I, , Oincreased VBN Oto TO Obetween IN B$ $ I69.5 CD Imillion CD Iand CC I$ $ I76 CD Imillion CD I, , Ofrom IN O$ $ B47.1 CD Imillion CD Ithe DT Byear-before JJ Iperiod NN I. . OAnalysts NNS Bestimate VBP OColgate NNP B's POS Bworld-wide JJ Ithird-quarter JJ Isales NNS Irose VBD Oabout IN B8 CD I% NN Ito TO O$ $ B1.29 CD Ibillion CD I. . OMr. NNP BMark NNP Iattributed VBD Othe DT Bearnings NNS Igrowth NN Ito TO Ostrong JJ Bsales NNS Iin IN OLatin NNP BAmerica NNP I, , OAsia NNP Band CC OEurope NNP B. . OResults NNS Bwere VBD Oalso RB Obolstered VBN Oby IN O`` `` Ba DT Ivery RB Imeaningful JJ I'' '' Iincrease NN Iin IN Ooperating VBG Bprofit NN Iby IN OColgate NNP B's POS BU.S. NNP Ibusiness NN I, , OMr. NNP BMark NNP Isaid VBD O. . OOperating NN Bprofit NN Iat IN OColgate NNP B's POS BU.S. NNP Ihousehold NN Iproducts NNS Iand CC Ipersonal-care JJ Ibusinesses NNS Ijumped VBD O25 CD B% NN Iin IN Othe DT Bquarter NN I, , OMr. NNP BMark NNP Iadded VBD O. . OHe PRP Bsaid VBD Othe DT Bimprovement NN Iwas VBD Oa DT Bresult NN Iof IN Ocost NN Bsavings NNS Iachieved VBN Oby IN Oconsolidating VBG Omanufacturing NN Ooperations NNS B, , Oblending VBG Otwo CD Bsales NNS Iorganizations NNS Iand CC Ofocusing VBG Omore RBR Ocarefully RB Othe DT Bcompany NN I's POS Bpromotional JJ Iactivities NNS I. . OThe DT Bestimated VBN Iimprovement NN Iin IN OColgate NNP B's POS BU.S. NNP Ioperations NNS Itook VBD Osome DT Banalysts NNS Iby IN Osurprise NN B. . OColgate NNP B's POS Bhousehold NN Iproducts NNS Ibusiness NN I, , Owhich WDT Bincludes VBZ Osuch JJ Bbrands NNS Ias IN OFab NNP Blaundry NN Idetergent NN Iand CC OAjax NNP Bcleanser NN I, , Ohas VBZ Obeen VBN Oa DT Bweak JJ Iperformer NN I. . OAnalysts NNS Bestimate VBP OColgate NNP B's POS Bsales NNS Iof IN Ohousehold NN Bproducts NNS Iin IN Othe DT BU.S. NNP Iwere VBD Oflat JJ Ofor IN Othe DT Bquarter NN I, , Oand CC Othey PRP Bestimated VBD Ooperating VBG Bmargins NNS Iat IN Oonly RB B1 CD I% NN Ito TO I3 CD I% NN I. . O`` `` OIf IN Oyou PRP Bcould MD Osay VB Otheir PRP$ Bbusiness NN Iin IN Othe DT BU.S. NNP Iwas VBD Omediocre JJ O, , Obut CC Ogreat JJ Oeverywhere RB Oelse RB O, , Othat WDT Bwould MD Obe VB Ofine JJ O, , O'' '' Osays VBZ OBonita NNP BAustin NNP I, , Oan DT Banalyst NN Iwith IN OWertheim NNP BSchroder NNP I& CC ICo NNP I. . O`` `` OBut CC Oit PRP B's VBZ Onot RB Omediocre JJ O, , Oit PRP B's VBZ Oa DT Breal JJ Iproblem NN I. . O'' '' OMr. NNP BMark NNP Iconceded VBD Othat IN OColgate NNP B's POS Bdomestic JJ Ibusiness NN I, , Oapart RB Ofrom IN Oits PRP$ Ohighly RB Oprofitable JJ OHill NNP B's POS IPet NNP OProducts NNPS Ounit NN O, , Ohas VBZ Olagged VBN O. . O`` `` OWe PRP B've VBP Odone VBN Oa DT Blot NN Ito TO Oimprove VB O-LCB- ( BU.S. NNP I. . I-RCB- ) Iresults NNS I, , Oand CC Oa DT Blot NN Imore JJR Iwill MD Obe VB Odone VBN O, , O'' '' OMr. NNP BMark NNP Isaid VBD O. . O`` `` OImproving VBG Oprofitability NN Bof IN OU.S. NNP Boperations NNS Iis VBZ Oan DT Bextremely RB Ihigh JJ Ipriority NN Iin IN Othe DT Bcompany NN I. . O'' '' OTo TO Ofocus VB Oon IN Oits PRP$ Bglobal JJ Iconsumer-products NNS Ibusiness NN I, , OColgate NNP Bsold VBD Oits PRP$ BKendall NNP Ihealth-care NN Ibusiness NN Iin IN O1988 CD B. . OH. NNP BAnthony NNP IIttleson NNP Iwas VBD Oelected VBN Oa DT Bdirector NN Iof IN Othis DT Bcompany NN I, , Owhich WDT Bprimarily RB Ohas VBZ Ointerests NNS Bin IN Oradio NN Band CC Itelevision NN Istations NNS I, , Oincreasing VBG Othe DT Bnumber NN Iof IN Oseats NNS Bto TO Ofive CD B. . OOsborn NNP Balso RB Ooperates VBZ OMuzak NNP Bfranchises NNS I, , Oentertainment NN Bproperties NNS Iand CC Osmall JJ Bcable-television NN Isystems NNS I. . OMr. NNP BIttleson NNP Iis VBZ Oexecutive NN B, , Ospecial JJ Bprojects NNS I, , Oat IN OCIT NNP BGroup NNP IHoldings NNP IInc. NNP I, , Owhich WDT Bis VBZ Ocontrolled VBN Oby IN OManufacturers NNP BHanover NNP ICorp NNP I. . OThe DT BBoston NNP IGlobe NNP Isays VBZ Oits PRP$ Bnewly RB Iredesigned VBN Ipages NNS Ihave VBP Oa DT B`` `` Icrisper NN I'' '' Ilook VB Iwith IN Orevamped VBN Bfixtures NNS Iaimed VBN Oat IN Omaking VBG Othe DT Bpaper NN I`` `` Omore RBR Oconsistent JJ O'' '' Oand CC O`` `` Oeasier JJR Oto TO Oread VB O. . O'' '' OMaybe RB Oso RB O-- : Oif IN Oyou PRP Bcan MD Ofind VB Owhere WRB Oyour PRP$ Bfavorite JJ Iwriter NN Iwent VBD O. . OBeantown NNP Bscribes NNS I, , Owho WP Bspare VB Ono DT Binvective NN Iwhen WRB Otaking VBG O